You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

event free survival

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

Recruiting
  • Prostate Cancer
  • +6 more
  • Radiotherapy (SBRT) and/or surgery (metastasectomy)
  • +2 more
  • Leuven, Belgium
    University Hospitals Leuven
Jun 7, 2022

Osteogenic Sarcoma Recurrent Trial in Hackensack, Houston (Iscador*P)

Not yet recruiting
  • Osteogenic Sarcoma Recurrent
  • Hackensack, New Jersey
  • +1 more
Feb 3, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Myrtle Beach (Darolutamide, Enzalutamide, Radium-223)

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Enzalutamide during Lead-in Period
  • +5 more
  • Myrtle Beach, South Carolina
    Research Site
Sep 9, 2022

Diffuse Large B Cell Lymphoma Trial in France (Adapted physical activity)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Adapted physical activity
  • Besançon, France
  • +4 more
Oct 7, 2021

Event-free Survival, Overall Survival, Local-recurrence Free Survival Trial in Beijing (Cisplatin)

Completed
  • Event-free Survival
  • +3 more
  • Beijing, Beijing, China
    Peking University People's Hospital
Jan 2, 2021

Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)

Not yet recruiting
  • Metastatic Prostate Cancer
  • (no location specified)
Mar 6, 2023

Severe Toxicity Free Survival Following Childhood Acute

Recruiting
  • Acute Lymphoblastic Leukemia
    • Copenhagen, Denmark
      Kjeld Schmiegelow
    Dec 9, 2022

    Prognostic Factors Affecting Recurrence and Disease-Free

    Recruiting
    • Rectal Cancer
    • curative surgery for cancer rectum
    • Qinā, Egypt
      Qena Faculty of Medicine, South Valley University Hospitals
    Oct 21, 2023

    Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Neoadjuvant
    • Axitinib plus Toripalimab
    • radical nephrectomy
    • (no location specified)
    Feb 12, 2023

    Crestal Bone Loss, Survival Rate Trial in Cairo (placement of dental implants)

    Completed
    • Crestal Bone Loss
    • Survival Rate
    • placement of dental implants
    • Cairo, Egypt
      Ain Shams University
    Oct 21, 2023

    Improving Liver Transplant-free Survival in Acute Decompensation

    Not yet recruiting
    • Decompensated Cirrhosis
    • No intervention
    • New Delhi, Delhi, India
      Institute of Liver & Biliary Sciences
    Jul 12, 2023

    Disease-free Survival of High-risk Head-neck Cutaneous Squamous

    Active, not recruiting
    • Carcinoma, Squamous Cell
    • +5 more
    • Treatment
    • Maastricht, Netherlands
    • +1 more
    Apr 26, 2023

    Prostate Cancer, Node; Prostate, Radiotherapy Side Effect Trial in Quebec (Report and compare changes in a non-inferiority

    Recruiting
    • Prostate Cancer
    • +2 more
    • Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
    • +7 more
    • Quebec, Canada
      CHUdeQuebec
    Apr 7, 2023

    Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant

    Completed
    • The Primary Study Metric is Progression-free Survival (PFS)
      • (no location specified)
      Jun 28, 2023

      Textbook Outcome in Colon Carcinoma

      Completed
      • Outcome Assessment
      • Cancer of Colon
      • Colon oncological resection
      • Alicante, Spain
        Hospital General Universitario Dr. Balmis
      Jan 5, 2023

      Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

      Terminated
      Has Results
      • Breast Neoplasms
      • Saint Louis, Missouri
        Washington University School of Medicine
      Oct 31, 2022

      Meningioma, Meningioma Atypical, Anaplastic Meningioma Trial in Rome (Biological biomarker assessment)

      Recruiting
      • Meningioma
      • +2 more
      • Biological biomarker assessment
      • Rome, Italy
        Fondazione Policlinico Universitario A. Gemelli IRCCS
      Mar 29, 2023

      Bladder Cancer, Bladder Urothelial Carcinoma Trial in Toronto (re-TURBT, 6 weeks BCG instillation)

      Terminated
      • Bladder Cancer
      • Bladder Urothelial Carcinoma
      • re-TURBT
      • 6 weeks BCG instillation
      • Toronto, Ontario, Canada
        University Health Network
      Apr 12, 2022

      to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally

      Recruiting
      • to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
      • Capecitabine 500Mg Oral Tablet
      • Shanghai, China
        Eye & ENT Hospital, Fudan University
      Jul 2, 2023

      Overall Survival, Progression-free Survival, Cost Trial (Microwave Ablation)

      Completed
      • Overall Survival
      • +2 more
      • Microwave Ablation
      • (no location specified)
      Apr 1, 2023

      Pancreatic Cancer, Thromboembolism Trial in Athens (Innohep, Chemotherapy: Gemcitabine + Nab-Paclitaxel)

      Recruiting
      • Pancreatic Cancer
      • Thromboembolism
      • Innohep
      • Chemotherapy: Gemcitabine + Nab-Paclitaxel
      • Athens, Attiki, Greece
      • +1 more
      Mar 28, 2022

      Independent Living, Disability Free Survival, Elderly Trial in Australia (Atorvastatin, Placebo (for Atorvastatin))

      Recruiting
      • Independent Living
      • +3 more
      • Hobart, Tasmania, Australia
      • +5 more
      Nov 28, 2022

      Disease Free Survival, Overall Survival, Pancreatic Cancer Trial in Milan (use of targeted drugs such as aspirin, B-Blockers,

      Recruiting
      • Disease Free Survival
      • +2 more
      • use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins
      • Milan, Italy
        IRCCS San Raffaele
      Mar 7, 2022

      Progression-free Survival Trial (Sovalteinib Solutumab Tegeo)

      Not yet recruiting
      • Progression-free Survival
      • Sovalteinib Solutumab Tegeo
      • (no location specified)
      Jul 24, 2023

      Survival in Adult MRD Positive Acute Lymphoblastic Leukemia

      Completed
      • Acute Lymphoblastic Leukemia
        • Brno, Czechia
        • +9 more
        Sep 12, 2022